Revive Therapeutics Ltd.
Revive Therapeutics Ltd.
Revive Therapeutics Ltd. is a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, and it is prioritizing drug development efforts to take advantage of several regulatory incentives awarded by the FDA such as Orphan Drug, Fast Track, Breakthrough Therapy and Rare Pediatric Disease designations. Currently, the Company is exploring the use of Bucillamine for the potential treatment of infectious diseases, with an initial focus on severe influenza strains including COVID-19. With its recent acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. Revive’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted FDA orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation. For more information visit www.ReviveThera.com.
Revive Therapeutics Ltd. (RVV)
Revive Therapeutics Ltd. (RVV)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
|---|---|---|---|---|---|
| BMO Nesbitt Burns Inc. | 198,000 | 0.03 | 0.035 | 50,000 | Scotia Capital Inc. |
| iA Private Wealth Inc. | 100,000 | 0.03 | 0.035 | 160,000 | Interactive Brokers Canada Inc. |
| TD Securities Inc. | 16,000 | 0.03 | 0.035 | 18,000 | TD Securities Inc. |
| TD Securities Inc. | 50,000 | 0.03 | 0.035 | 38,000 | TD Securities Inc. |
| TD Securities Inc. | 40,000 | 0.03 | 0.035 | 186,000 | National Bank Financial Inc. |
| Scotia Capital Inc. | 22,000 | 0.03 | 0.035 | 31,000 | TD Securities Inc. |
| National Bank Financial Inc. | 3,000 | 0.03 | 0.04 | 30,000 | Scotia Capital Inc. |
| BMO Nesbitt Burns Inc. | 250,000 | 0.03 | 0.04 | 1,000 | Questrade Inc. |
| TD Securities Inc. | 20,000 | 0.03 | 0.04 | 168,000 | CIBC World Markets Inc. |
| TD Securities Inc. | 10,000 | 0.03 | 0.04 | 1,000 | Questrade Inc. |
| Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
|---|---|---|---|---|---|
| Anonymous | 100,000 | 0.01 | 0.00 | 0 | |
| Anonymous | 600,000 | 0.005 | 0.00 | 0 | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
|---|---|---|---|---|---|
| 12 | 714,000 | 0.03 | 0.035 | 483,000 | 6 |
| 5 | 243,000 | 0.025 | 0.04 | 336,000 | 11 |
| 7 | 359,000 | 0.02 | 0.045 | 211,000 | 5 |
| 14 | 495,000 | 0.015 | 0.05 | 48,000 | 5 |
| 15 | 1,450,000 | 0.01 | 0.055 | 12,000 | 3 |
| Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
|---|---|---|---|---|---|
| 1 | 100,000 | 0.01 | 0.00 | 0 | 0 |
| 1 | 600,000 | 0.005 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Heure | Prix | Modifier | Volume | Acheteur | Vendeur | Venue |
|---|---|---|---|---|---|---|
| Apr 17, 19:59 | 0.03 | 0.00 | 37,000 | BMO Nesbitt Burns Inc. | Anonymous | CSE |
| Apr 17, 19:58 | 0.03 | 0.00 | 6,000 | TD Securities Inc. | TD Securities Inc. | CSE |
| Apr 17, 19:58 | 0.03 | 0.00 | 3,000 | TD Securities Inc. | TD Securities Inc. | CSE |
| Apr 17, 19:52 | 0.03 | 0.00 | 62,000 | BMO Nesbitt Burns Inc. | CIBC World Markets Inc. | CSE |
| Apr 17, 16:47 | 0.03 | 0.00 | 17,000 | Instinet Canada Limited | Questrade Inc. | CSE2 |
Information d'entreprise
SEDAR Information
Information d'entreprise
Capitalisation
Communiqués de presse
Bulletins
2019-0718 – Nouvelle Inscription - Revive Therapeutics Ltd. (RVV)
le 19 juillet/July 2019
The common shares of Revive Therapeutics Ltd. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
